NIH supports small-scale mechanistic or minimal-risk clinical trials at health professional and graduate schools with limited NIH funding, enhancing student research experiences and institutional research capacity.
Funder: National Institutes of Health
Due Dates: February 25, 2027 (Applications) | June 25, 2027 (Applications) | October 25, 2027 (Applications)
Funding Amounts: Up to $375,000 in direct costs, excluding consortium F&A, over up to 3 years
Summary: Supports small-scale clinical trials at NIH-limited health professional and graduate schools while engaging students in biomedical research.
Key Information: Each PI must have a qualifying primary appointment and cannot hold an active NIH research grant at award.
The NIH Research Enhancement Award Program (REAP) supports meritorious small-scale research at health professional and graduate schools that have not been major recipients of NIH funding. Its goals are to strengthen institutional research environments and give health professional, undergraduate, and graduate students significant biomedical research experience through active participation.
This R15 opportunity requires investigator-initiated mechanistic and/or minimal-risk clinical trials aligned with participating NIH institutes’ missions. Responsive trials do not require FDA oversight, pose low potential for physical or psychological harm, and inform subsequent studies rather than establish efficacy or directly change policy or standard of care. Research teams must consist primarily of students from eligible institutional components. REAP is a research grant, not a training or fellowship program.